Sources | Names Used |
---|---|
CTRPv2 | selumetinib:decitabine (4:1 mol/mol) |
PharmacoGx | selumetinib:decitabine (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SPRY4 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
mRNA | TAPT1 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
mRNA | SH3TC2 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
mRNA | VASN | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
mRNA | PLCB2 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | ERBB3 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
mRNA | AAED1 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
mRNA | SNX25 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
mRNA | SNTA1 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
mRNA | RABAC1 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |